This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human MMP-8 Magnetic Luminex® Performance Assay
catalog :
LMPM908
quantity :
1 Kit
price :
200 USD
citations: 3
| Reference |
|---|
Albuquerque V, Kumar N, Fukutani K, Vasconcelos B, Arriaga M, Silveira Mattos P, et al. Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in children. Cytokine. 2019;123:154773 pubmed publisher
|
product information
master code :
LMPM908
SKU :
LMPM908
product name :
Human MMP-8 Magnetic Luminex® Performance Assay
unit size :
1 Kit
target :
MMP-8
category :
Luminex Assays
species :
Human
gene symbol :
MMP8
url print :
?utm_source=labome&utm_medium=referral&utm_campaign=product&utm_term=luminexassays
kit type :
Magnetic bead-based multiplex assay for the Luminex MAGPIX platform
elisaSampleTypes :
Cell Culture Supernates (10 uL), Serum (10 uL), Heparin Plasma (10 uL), Platelet-poor Heparin Plasma (10 uL), Saliva (10 uL), Urine (10 uL)
USD :
200 USD
alt names :
CLG1HNC, Collagenase 2, EC 3.4.24, EC 3.4.24.34, matrix metallopeptidase 8 (neutrophil collagenase), matrix metalloproteinase 8 (neutrophil collagenase), Matrix metalloproteinase-8, MMP8, MMP-8, neutrophil collagenase, PMNL collagenase, PMNL-CL
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
questions and comments
